Amivantamab and lazertinib in treatment-naive EGFR-mutated advanced non-small-cell lung cancer (NSCLC): Long-term follow-up and ctDNA results from CHRYSALIS.

JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 0|浏览31
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要